Companies · USAspending parent record

EMERGENT BIOSOLUTIONS INC

Stock ticker: EBS. 1 recipient record grouped under this USAspending parent (UEI DKEFA8JAW3X4).

Non-competed awards

$63.3M

obligated to date on 2 non-competed awards of $1M+ signed FY2024–26

USAspendingas of Oct 3

Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.

Awards in our records

2 non-competed ($1M+) · 0 other ($10M+)

USAspendingas of Oct 3

Largest award

$41.8M

obligated to date: W911SR24F0016, Department of Defense, signed FY2024

USAspendingas of Oct 3

Member trades

reported in EBS by 2 members of Congress

House Clerk + Senate eFDas of Oct 4

Filings: House 2021–2026 · Senate 2024–2026

Source: USAspending.gov · SEC EDGAR company tickers · House Clerk PTRs · Senate eFDCoverage: Contract awards FY2024–FY2026 · Ticker links FY2024–26 recipients · House 2021–2026 · Senate 2024–2026Updated: Oct 3, 2026, 6:55 PM ETMethodology →

Federal contract awards in our records

Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.

What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.

Awards by fiscal year signed (obligated to date, not spending in the year)
Signed in	Non-competed awards	Obligated to date	Other awards $10M+	Obligated to date
FY2024	1	$41.8M	None in this set	—
FY2025	None in this set	—	None in this set	—
FY2026incomplete	1	$21.5M	None in this set	—

FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.

FY2026 awards to EMERGENT BIOSOLUTIONS INC, largest first (obligated to date)
						Source
W911SR26FA005Order under IDV W911SR24D0001FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))	EMERGENT BIODEFENSE OPERATIONS LANSING LLC	Department of Defense	Jan 8, 2026FY2026	Not available for competitionOnly one source-other (FAR 6.302-1 other)	$21,534,000	USAspending

FY2026 awards to EMERGENT BIOSOLUTIONS INC, largest first (obligated to date)

W911SR26FA005Order under IDV W911SR24D0001FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))
EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Agency
Department of Defense
Signed
Jan 8, 2026FY2026
Competition
Not available for competitionOnly one source-other (FAR 6.302-1 other)
Obligated to date
$21,534,000
USAspending

1 award. Source: USAspending.gov award records.

Recipient records grouped under this company (1)

USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to EMERGENT BIOSOLUTIONS INC; the stock link below is made per recipient.

EMERGENT BIODEFENSE OPERATIONS LANSING LLC2 awards · 2 non-competed, $63.3M obligated to date

Stock ticker

Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.

EBSEmergent BioSolutions Inc.NYSESEC filings ↗

How these recipients were linked (1)

EMERGENT BIODEFENSE OPERATIONS LANSING LLCsubsidiary of the registrant (name match or SEC subsidiary list) · USAspending parent 'EMERGENT BIOSOLUTIONS INC' = registrant; recipient name starts with 'EMERGENT', a distinctive word of the parent name · rule r7-v1

A link says USAspending and SEC records tie this recipient to this registrant. It does not say a member’s trade or a company’s award means anything.

Members of Congress who reported trading this stock

Trades in EBS from STOCK Act disclosures, newest filing first.

Two public records, side by side. The company holds federal contracts, and members reported trades in its stock. That is a pattern in the records, not an accusation: trades can be routine, made by a spouse or a managed account, and a sequence of events is not proof of wrongdoing. Amounts are the ranges members disclosed; they are never added up into a single figure, and “2 ×” means two same-day lots, each in that range.

2 members · 5 reported trades

Members who reported trades in this stock, by number of reported trades

Josh Gottheimer	D · NJ · House	4	1	3	0	0	Dec 13, 2021
Steve Cohen	D · TN · House	1	0	1	0	0	Jan 10, 2025

Josh Gottheimer
D · NJ · House
Reported trades
4
Purchases
1
Sales
3
Exchanges
0
Options and other
0
Latest filing
Dec 13, 2021
Steve Cohen
D · TN · House
Reported trades
1
Purchases
0
Sales
1
Exchanges
0
Options and other
0
Latest filing
Jan 10, 2025

Every reported trade, with its filing

Reported trades in EBS, newest filing first
					Filing
Steve CohenD · TN · House · owner: Self (incl. trusts/accounts)	EBS Emergent BioSolutions Inc. Common Stock	Sale	$1,001–$15,000	Dec 11, 2024 → Jan 10, 2025	View filing
Josh GottheimerD · NJ · House · owner: Joint	EBS Emergent biosolutions, Inc.	Sale	$1,001–$15,000	Nov 5, 2021 → Dec 13, 2021	View filing
Josh GottheimerD · NJ · House · owner: Joint	EBS Emergent biosolutions, Inc.	Purchase	$1,001–$15,000	Oct 18, 2021 → Nov 15, 2021	View filing
Josh GottheimerD · NJ · House · owner: Joint	EBS Emergent biosolutions, Inc.	Sale	$1,001–$15,000	Sep 15, 2021 → Oct 13, 2021	View filing
Josh GottheimerD · NJ · House · owner: Joint	EBS Emergent biosolutions, Inc.	Sale	$1,001–$15,000	Feb 23, 2021 → Mar 10, 2021	View filing

Reported trades in EBS, newest filing first

Steve CohenD · TN · House · owner: Self (incl. trusts/accounts)
EBS Emergent BioSolutions Inc. Common Stock
Type
Sale
Amount (range)
$1,001–$15,000
Traded → filed
Dec 11, 2024 → Jan 10, 2025
View filing
Josh GottheimerD · NJ · House · owner: Joint
EBS Emergent biosolutions, Inc.
Type
Sale
Amount (range)
$1,001–$15,000
Traded → filed
Nov 5, 2021 → Dec 13, 2021
View filing
Josh GottheimerD · NJ · House · owner: Joint
EBS Emergent biosolutions, Inc.
Type
Purchase
Amount (range)
$1,001–$15,000
Traded → filed
Oct 18, 2021 → Nov 15, 2021
View filing
Josh GottheimerD · NJ · House · owner: Joint
EBS Emergent biosolutions, Inc.
Type
Sale
Amount (range)
$1,001–$15,000
Traded → filed
Sep 15, 2021 → Oct 13, 2021
View filing
Josh GottheimerD · NJ · House · owner: Joint
EBS Emergent biosolutions, Inc.
Type
Sale
Amount (range)
$1,001–$15,000
Traded → filed
Feb 23, 2021 → Mar 10, 2021
View filing

Source: House Clerk PTRs and Senate eFD. Amounts are disclosed ranges; “2 ×” means two same-day lots, each in that range. “Filed” is the first report; a later amendment is noted under it and linked beside the filing. In House filings, owner “Self” includes trusts and accounts filed without an owner. Options are labelled as options, never as a purchase or sale of the stock.

Looking for agency-level shares? See non-competed share by agency.